Haddadin Yezan Munther

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
3 Oct 24	OTLK Outlook Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	5.25	19,771	103.80 k	19,771
1 Oct 24	OTLK Outlook Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	5.22	132,293	690.57 k	132,293
1 Oct 24	OTLK Outlook Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	5.22	56,636	295.64 k	56,636
28 Mar 24	OTLK Outlook Therapeutics	Common Stock	Buy	Acquire P	No	No	11.82	1,881.711	22.24 k	5,048.711
7 Mar 24	OTLK Outlook Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	0.41	94,441	38.72 k	94,441
4 Oct 23	OTLK Outlook Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	0.24	358,337	86.00 k	358,337

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.